Red Flags in Clinical Lab Operations Rise from Recent Court Cases
Guilty plea points to patient data collection, while settlement implicates an undisclosed relationship
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Guilty plea points to patient data collection, while settlement implicates an undisclosed relationship
CEO Laurie Menser discusses the Association for Molecular Pathology’s court case against the FDA’s rule on laboratory-developed tests.
The most common AI compliance risk areas related to data security and patient privacy, and the current regulatory landscape
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
Though needed to protect data and patient privacy, some in the industry say that more flexibility is needed
Why ongoing coaching and learning is required for laboratory sales reps—even experienced ones—to help labs meet their business goals
The rounds of funding to Clarapath, PreciseDx, and Precision Epigenomics come at a time when other M&A activity is seasonally slow
Recent government efforts to address increased cyberattacks in the healthcare space, and how your lab could benefit
Though payers’ adoption of AI has made reimbursement more challenging for labs, providers can also use AI to address these issues
The agency has approved fewer than 10 tests in the past three years, but a new pipeline of AI-powered products is expected to emerge soon
A guide to understanding, implementing, and benefiting from digital pathology and artificial intelligence in the clinical lab